{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-000410","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.889904+00:00","generated_at":"2026-06-04T16:54:03.208333+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lexaria Bioscience appoints Nelson Cabatuan as CFO effective March 14, 2024","bullets":["Nelson Cabatuan, age 46, replaces temporary outsourced CFO services from NOW CFO.","Base annual salary of US$198,000 with agreed annual increases of US$12,000 for first two years.","Option grant of up to 200,000 common shares vested over three years; performance bonuses up to 35-50% of base.","Exit compensation: upon sale of affiliate, 0.5%-1.0% of gross sale value; change-of-control triggers 12-14 months base salary.","Cabatuan brings over 15 years biotech finance experience; previously SVP at Rain Oncology and VP at Rigel Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-000410","json":"https://secwatch.observer/filing/0001640334-24-000410.json","markdown":"https://secwatch.observer/filing/0001640334-24-000410.md","text":"https://secwatch.observer/filing/0001640334-24-000410.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/0001640334-24-000410-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T16:54:03.208333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"140190acf5","claim":"Nelson Cabatuan was appointed as Chief Financial Officer at Lexaria Bioscience Corp..","evidence_excerpt":"Effective March 14, 2024, Nelson Cabatuan, age 46, has been appointed to the position of Chief Financial Officer of Lexaria Bioscience Corp.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/0001640334-24-000410-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}